Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Exchange Rate Effect: 2015-2025

Historic Exchange Rate Effect for KalVista Pharmaceuticals (KALV) over the last 11 years, with Apr 2025 value amounting to $2.6 million.

  • KalVista Pharmaceuticals' Exchange Rate Effect rose 4645.95% to $3.4 million in Q2 2025 from the same period last year, while for Apr 2025 it was $3.8 million, marking a year-over-year increase of 414.43%. This contributed to the annual value of $2.6 million for FY2025, which is 317.56% up from last year.
  • KalVista Pharmaceuticals' Exchange Rate Effect amounted to $2.6 million in FY2025, which was up 317.56% from -$1.2 million recorded in FY2024.
  • Over the past 5 years, KalVista Pharmaceuticals' Exchange Rate Effect peaked at $2.6 million during FY2025, and registered a low of -$1.2 million during FY2024.
  • Moreover, its 3-year median value for Exchange Rate Effect was $1.2 million (2023), whereas its average is $887,333.
  • Per our database at Business Quant, KalVista Pharmaceuticals' Exchange Rate Effect slumped by 328.38% in 2022 and then soared by 317.56% in 2025.
  • Over the past 5 years, KalVista Pharmaceuticals' Exchange Rate Effect (Yearly) stood at $511,000 in 2021, then slumped by 328.38% to -$1.2 million in 2022, then surged by 205.91% to $1.2 million in 2023, then slumped by 198.14% to -$1.2 million in 2024, then soared by 317.56% to $2.6 million in 2025.